TrialReproductive biology and endocrinology : RB&E2016

Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART).

Thomas Strowitzki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.